Related references
Note: Only part of the references are listed.Concordance between practice and published evidence in the management of ANCA-associated vasculitis in Japan: A cross-sectional web-questionnaire survey
Yoshia Miyawaki et al.
MODERN RHEUMATOLOGY (2023)
Systematic review and meta-analysis for 2023 clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of ANCA-associated vasculitis
Ryu Watanabe et al.
MODERN RHEUMATOLOGY (2023)
Avacopan for the Treatment of ANCA-Associated Vasculitis
David R. W. Jayne et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Effect of Reduced-Dose vs High-Dose Glucocorticoids Added to Rituximab on Remission Induction in ANCA-Associated Vasculitis A Randomized Clinical Trial
Shunsuke Furuta et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
Sharon A. Chung et al.
ARTHRITIS & RHEUMATOLOGY (2021)
Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis
Michael Walsh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Long-Term Rituximab Use to Maintain Remission of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis A Randomized Trial
Pierre Charles et al.
ANNALS OF INTERNAL MEDICINE (2020)
2017 Clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of ANCA-associated vasculitis
Masayoshi Harigai et al.
MODERN RHEUMATOLOGY (2019)
Mycophenolate Mofetil Versus Cyclophosphamide for the Induction of Remission in Nonlife-Threatening Relapses of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Randomized, Controlled Trial
Janneke Tuin et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial
Rachel B. Jones et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Efficacy and Safety of Belimumab and Azathioprine for Maintenance of Remission in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Randomized Controlled Study
David Jayne et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Long-term efficacy of remission-maintenance regimens for ANCA-associated vasculitides
Benjamin Terrier et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2)
Pierre Charles et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Comparison of the Phenotype and Outcome of Granulomatosis with Polyangiitis Between UK and Japanese Cohorts
Shunsuke Furuta et al.
JOURNAL OF RHEUMATOLOGY (2017)
Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis
David R. W. Jayne et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Randomised controlled trial of prolonged treatment in the remission phase of ANCA-associated vasculitis
Alexandre Karras et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis
M. Yates et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Extended versus standard azathioprine maintenance therapy in newly diagnosed proteinase-3 anti-neutrophil cytoplasmic antibody-associated vasculitis patients who remain cytoplasmic anti-neutrophil cytoplasmic antibody-positive after induction of remission: a randomized clinical trial
Jan-Stephan F. Sanders et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2016)
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial
Rachel B. Jones et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Comparison of Phenotype and Outcome in Microscopic Polyangiitis Between Europe and Japan
Shunsuke Furuta et al.
JOURNAL OF RHEUMATOLOGY (2014)
Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis
L. Guillevin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis
Eleana Ntatsaki et al.
RHEUMATOLOGY (2014)
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
J. C. Jennette et al.
ARTHRITIS AND RHEUMATISM (2013)
Effects of Mycophenolate Mofetil Combined with Corticosteroids for Induction Therapy of Microscopic Polyangiitis
Fei Han et al.
AMERICAN JOURNAL OF NEPHROLOGY (2011)
Plasma exchange for induction and cyclosporine A for maintenance of remission in Wegener's granulomatosis-a clinical randomized controlled trial
Wladimir M. Szpirt et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the UK
Shouichi Fujimoto et al.
RHEUMATOLOGY (2011)
Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis.
John H. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis.
Rachel B. Jones et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement
Weixin Hu et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Predictive value of initial histology and effect of plasmapheresis on long-term prognosis of rapidly progressive glomerulonephritis
I Zaner et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2002)
Share Paper
